Tillmann out as Roche Diagnostics CEO
The management change comes as the Indianapolis company’s diabetes market share has been sliding. Roche says successor will
be named “shortly.”
J.K. Wall
Articles
Adversity prepared health exec for new role at helm of SynCare
Stephanie DeKemper believes everything in her adult life has prepared her to run SynCare LLC. She’s so
sure that she’s buying the company.
State high school graduation rates keep rising
According to data released Friday by the Indiana Department of Education, 81.2 percent of Hoosier high school students scheduled
to graduate in 2009 did.
Doctors resume battle with Anthem, health insurers
Doctors are pushing again to strengthen their hands in contract negotiations with health insurers, especially market leader
Anthem Blue Cross and Blue Shield.
Health providers learn long-awaited definition
Last week, the U.S. Department of Health and Human Services finally defined the "meaningful use" standard for
hospitals and doctors to receive subsidies to install electronic health records.
Health spending slows even before reform
Health spending is growing slower than it has in 48 years—but that’s better news for businesses and households
than it is for governments. Whether health care reform will continue the trend is an open question.
Grass-roots groups prepare to fill gaps in health care reform
Legislation set to come out of Washington will not change the most fundamental problems of the health
care system, leaving it up to states, cities and companies to figure out what to do about it.
Physicians face fee cuts from Medicare
Specialists lose, primary docs win in new Medicare payment rates. All hope Congress acts to avert a scheduled 21-percent cut for everyone.
Corporations bet on insiders to bend reform
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional
leaders and committees in health reform process.
To keep sales force busy, Lilly takes on new drug
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel
to push.
Lilly scurries to get out from under Zyprexa cloud
Another year of rapid change at Eli Lilly and Co. did little to move the company out from under the cloud cast by its best-selling
drug, Zyprexa.
Health care industry braces for reform
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity
late in the year.
First decade of century marked by buyouts and bubbles
The decade witnessed a massive terrorist attack, two wars, and a building-and-buyout boom fueled by easy credit.
Conservatives, liberals unite in criticizing health bill
We talk about the spectrum of political ideology, but last week on health care reform, it became more of a circle as liberals
joined conservatives in criticizing the Senate health reform bill.
Investors cheer Senate bill while WellPoint cries foul
Exemption for not-for-profit health plans could saddle WellPoint with nearly $2 billion a year in new taxes.
Hoosier biz groups oppose Senate health bill
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
Setbacks in diabetes market batter Roche
Roche Diagnostics Corp., once the darling of the U.S. diabetes-device market, is now licking its wounds. And
it’s mulling whether to keep fighting on all fronts or to pull back.
Senate bucks public opinion
Polls show public likes proposed Medicare expansion and public option, but does not like overall Senate bill.
Think tank hired to put state under microscope
Mathematica Policy Research, which last studied Indiana in 2004, will now examine Healthy Indiana Plan.